Valuation: Illumina, Inc.

Market Cap 40.77B 35.78B 33.79B 30.79B 57.64B 3,908B 58.05B 404B 157B 1,996B 153B 150B 6,416B P/E 2026 *
54.6x
P/E 2027 * 45.6x
Enterprise Value 40.65B 35.67B 33.69B 30.7B 57.48B 3,897B 57.89B 403B 156B 1,991B 153B 149B 6,398B EV / Sales 2026 *
8.79x
EV / Sales 2027 * 8.09x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-1.42%
1 week+12.68%
Current month+26.39%
1 month+18.58%
3 months+52.93%
6 months+129.46%
Current year+105.86%
1 week 234.57
Extreme 234.57
277.95
1 month 200.01
Extreme 200.01
277.95
Current year 112.65
Extreme 112.65
277.95
1 year 88
Extreme 88
277.95
3 years 68.7
Extreme 68.7
277.95
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap. Importance
9/8/26 Free

General Counsel

29,377 0.0195%
9/5/26 Tax

Chief Technology Officer

-408 0.0003%
9/4/26
Corvex Management LP
SellCompany -119,501 0.0791%
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%+12.68%+194.47%+102.55% 40.77B
-0.50%+3.62%+45.40%+35.46% 250B
+0.32%+5.99%+21.45%-9.27% 158B
+1.42%+3.01%-8.15%+39.03% 143B
-1.70%+1.34%-55.27%-15.70% 63.65B
+0.65%-2.23%+13.17%+23.08% 49.74B
-0.03%+10.43%+40.04%+56.37% 48.71B
+1.56%+0.05%-16.49%-20.04% 47.94B
+0.75%+2.82%+48.62%+59.19% 42.59B
+0.05%-1.33%-17.86%+49.34% 31.76B
Average +0.11%+3.64%+26.54%+32.00% 87.57B
Weighted average by Cap. +0.12%+3.84%+24.30%+26.47%

Financials

2026 *2027 *
Net sales 4.62B 4.06B 3.83B 3.49B 6.54B 443B 6.58B 45.86B 17.76B 226B 17.36B 16.99B 728B 4.92B 4.32B 4.08B 3.72B 6.95B 471B 7B 48.78B 18.89B 241B 18.47B 18.07B 774B
Net income 772M 678M 640M 583M 1.09B 74.01B 1.1B 7.66B 2.97B 37.81B 2.9B 2.84B 122B 912M 800M 756M 689M 1.29B 87.37B 1.3B 9.04B 3.5B 44.64B 3.42B 3.35B 143B
Net Debt -116M -101M -95.81M -87.31M -163M -11.08B -165M -1.15B -444M -5.66B -434M -425M -18.19B -976M -856M -809M -737M -1.38B -93.55B -1.39B -9.68B -3.75B -47.79B -3.66B -3.59B -154B
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
26-09-25 US$270.00 -1.42% 5,031,975
26-09-24 US$273.90 +7.25% 3,480,312
26-09-23 US$255.38 +3.20% 2,301,113
26-09-22 US$247.46 +3.62% 2,642,518
26-09-21 US$238.82 -0.33% 3,188,895
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
270.00USD
Average target price
202.65USD
Spread / Average Target
-24.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock